144 related articles for article (PubMed ID: 38358420)
21. Pulmonary vein isolation by means of a novel cryoballoon technology in paroxysmal atrial fibrillation patients: 1-year outcome from a large Italian multicenter clinical registry.
Bianchi S; De Simone A; Iacopino S; Fassini G; Malacrida M; Rossi P; Stabile G; Petretta A; Tundo F; Cauti FM; Iuliano S; Filannino P; Moltrasio M; Morlacchi Bonfanti M; Pelargonio G; Pecora D; Ferraro A; Tondo C
Pacing Clin Electrophysiol; 2023 Nov; 46(11):1302-1309. PubMed ID: 37846769
[TBL] [Abstract][Full Text] [Related]
22. Relationship between time-to-isolation and freeze duration: Computational modeling of dosing for Arctic Front Advance and Arctic Front Advance Pro cryoballoons.
Getman MK; Wissner E; Ranjan R; Lalonde JP
J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2274-2282. PubMed ID: 31502304
[TBL] [Abstract][Full Text] [Related]
23. Initial clinical experience with the novel POLARx FIT cryoballoon system for pulmonary vein isolation in patients with atrial fibrillation.
Fukunaga H; Sekiguchi Y; Sawaguchi J; Hayashi Y; Asano S; Mabuchi K; Inoue K; Tanizaki K; Umemura J; Isobe M; Nitta J
Int J Cardiol Heart Vasc; 2024 Feb; 50():101326. PubMed ID: 38192687
[TBL] [Abstract][Full Text] [Related]
24. Catheter ablation using the third-generation cryoballoon provides an enhanced ability to assess time to pulmonary vein isolation facilitating the ablation strategy: Short- and long-term results of a multicenter study.
Aryana A; Kowalski M; O'Neill PG; Koo CH; Lim HW; Khan A; Hokanson RB; Bowers MR; Kenigsberg DN; Ellenbogen KA;
Heart Rhythm; 2016 Dec; 13(12):2306-2313. PubMed ID: 27503480
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of two different cryoballoon systems for treatment of paroxysmal atrial fibrillation: study protocol for a multicenter randomized controlled trial (CONTRAST-CRYO Trial).
Ikenouchi T; Miyazaki S; Nitta J; Sekiguchi Y; Kobori A; Nakamura K; Inamura Y; Murakami M; Sagawa Y; Sasaki Y; Inaba O; Yamauchi Y; Naito S; Hirakawa A; Sasano T
J Interv Card Electrophysiol; 2024 Jan; 67(1):5-12. PubMed ID: 38087145
[TBL] [Abstract][Full Text] [Related]
26. Novel cryoballoon ablation system for pulmonary vein isolation: multicenter assessment of efficacy and safety-ANTARCTICA study.
Heeger CH; Pott A; Sohns C; Riesinger L; Sommer P; Gasperetti A; Tondo C; Fassini G; Moser F; Lucas P; Weinmann K; Bohnen JE; Dahme T; Rillig A; Kuck KH; Wakili R; Metzner A; Tilz RR
Europace; 2022 Dec; 24(12):1917-1925. PubMed ID: 36026521
[TBL] [Abstract][Full Text] [Related]
27. Key characteristics for effective acute pulmonary vein isolation when using a novel cryoballoon technology: insights from the CHARISMA registry.
Iacopino S; Stabile G; Fassini G; De Simone A; Petretta A; Moltrasio M; La Rocca V; Placentino F; Riva S; Pesce F; Rossi P; Pelargonio G; Iuliano A; Tundo F; Colella J; Tondo C
J Interv Card Electrophysiol; 2022 Sep; 64(3):641-648. PubMed ID: 34853986
[TBL] [Abstract][Full Text] [Related]
28. Procedural performance between two cryoballoon systems for ablation of atrial fibrillation depends on pulmonary vein anatomy.
Menger V; Frick M; Sharif-Yakan A; Emrani M; Zink MD; Napp A; Marx N; Gramlich M
J Arrhythm; 2023 Jun; 39(3):341-351. PubMed ID: 37324756
[TBL] [Abstract][Full Text] [Related]
29. Phrenic nerve paralysis during cryoballoon ablation for atrial fibrillation: a comparison between the first- and second-generation balloon.
Casado-Arroyo R; Chierchia GB; Conte G; Levinstein M; Sieira J; Rodriguez-Mañero M; di Giovanni G; Baltogiannis Y; Wauters K; de Asmundis C; Sarkozy A; Brugada P
Heart Rhythm; 2013 Sep; 10(9):1318-24. PubMed ID: 23891574
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of pulmonary vein isolation with pulsed field ablation vs. novel cryoballoon ablation system for atrial fibrillation.
Badertscher P; Weidlich S; Knecht S; Stauffer N; Krisai P; Voellmin G; Osswald S; Sticherling C; Kühne M
Europace; 2023 Dec; 25(12):. PubMed ID: 38036293
[TBL] [Abstract][Full Text] [Related]
31. Acute procedural efficacy and safety of a novel cryoballoon for the treatment of paroxysmal atrial fibrillation: Results from the POLAR ICE study.
Martin CA; Tilz RRR; Anic A; Defaye P; Luik A; de Asmundis C; Champ-Rigot L; Iacopino S; Sommer P; Albrecht EM; Raybuck JD; Richards E; Cielen N; Yap SC;
J Cardiovasc Electrophysiol; 2023 Apr; 34(4):833-840. PubMed ID: 36786515
[TBL] [Abstract][Full Text] [Related]
32. Dissociated pulmonary vein activity after cryoballoon ablation and radiofrequency ablation for atrial fibrillation: a propensity score-matched analysis.
Tokutake K; Tokuda M; Matsuo S; Isogai R; Yokoyama K; Kato M; Narui R; Tanigawa S; Yamashita S; Miyanaga S; Yoshimura M; Yamane T
Heart Vessels; 2018 May; 33(5):529-536. PubMed ID: 29147788
[TBL] [Abstract][Full Text] [Related]
33. A randomized controlled trial of the size-adjustable cryoballoon vs conventional cryoballoon for paroxysmal atrial fibrillation: The CONTRAST-CRYO II trial rationale and design.
Kawamura I; Miyazaki S; Inamura Y; Nitta J; Kobori A; Nakamura K; Murakami M; Nakamura T; Inaba O; Sekiguchi Y; Asano S; Sasaki Y; Mizuno S; Naito S; Hirakawa A; Sasano T
Heart Rhythm O2; 2024 May; 5(5):301-306. PubMed ID: 38840770
[TBL] [Abstract][Full Text] [Related]
34. Individualized cryoballoon energy pulmonary vein isolation guided by real-time pulmonary vein recordings, the randomized ICE-T trial.
Chun KR; Stich M; Fürnkranz A; Bordignon S; Perrotta L; Dugo D; Bologna F; Schmidt B
Heart Rhythm; 2017 Apr; 14(4):495-500. PubMed ID: 27956248
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of a novel cryoballoon ablation system: multicentre comparison of 1-year outcome.
Knecht S; Sticherling C; Roten L; Badertscher P; Krisai P; Chollet L; Küffer T; Spies F; Völlmin G; Madaffari A; Mühl A; Baldinger SH; Servatius H; Tanner H; Osswald S; Reichlin T; Kühne M
Europace; 2022 Dec; 24(12):1926-1932. PubMed ID: 35727739
[TBL] [Abstract][Full Text] [Related]
36. Early Clinical Outcomes and Advantages of a Novel-Size Adjustable Second-Generation Cryoballoon: A Proof-of-Concept Study.
Schiavone M; Fassini G; Moltrasio M; Majocchi B; Tundo F; Casati F; Tondo C
J Clin Med; 2024 Feb; 13(5):. PubMed ID: 38592089
[No Abstract] [Full Text] [Related]
37. Cryoballoon ablation for pulmonary vein isolation in patients with atrial fibrillation: preliminary results using novel short-tip cryoballoon.
Koektuerk B; Yorgun H; Koektuerk O; Turan CH; Aksoy MN; Turan RG; Gorr E; Bansmann PM; Hoppe C; Horlitz M
J Interv Card Electrophysiol; 2016 Oct; 47(1):91-98. PubMed ID: 27189156
[TBL] [Abstract][Full Text] [Related]
38. The incidence of phrenic nerve injury during pulmonary vein isolation using the second-generation 28 mm cryoballoon.
Metzner A; Rausch P; Lemes C; Reissmann B; Bardyszewski A; Tilz R; Rillig A; Mathew S; Deiss S; Kamioka M; Toennis T; Lin T; Ouyang F; Kuck KH; Wissner E
J Cardiovasc Electrophysiol; 2014 May; 25(5):466-470. PubMed ID: 24400647
[TBL] [Abstract][Full Text] [Related]
39. Effect of pulmonary vein cryoballoon ablation in dogs with coolant-nitrogen.
Xie Y; Guo R; Yan M; Zhao T; Xu Y; Zhao D
J Thorac Dis; 2022 May; 14(5):1488-1496. PubMed ID: 35693593
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of a second-generation cryoballoon in the ablation of paroxysmal atrial fibrillation.
Martins RP; Hamon D; Césari O; Behaghel A; Behar N; Sellal JM; Daubert JC; Mabo P; Pavin D
Heart Rhythm; 2014 Mar; 11(3):386-93. PubMed ID: 24389575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
